Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hospital Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia”

15 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 15 results

Large-scale testing (Phase 3)WithdrawnNCT06168734
What this trial is testing

Cefepime-taniborbactam vs Meropenem in Adults With VABP or Ventilated HABP

Who this might be right for
Ventilator-associated PneumoniaHospital-acquired Pneumonia
Venatorx Pharmaceuticals, Inc.
Large-scale testing (Phase 3)Study completedNCT03583333
What this trial is testing

Imipenem/Cilastatin/Relebactam (MK-7655A) Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia (MK-7655A-016)

Who this might be right for
Hospital-Acquired Bacterial PneumoniaVentilator-Associated Bacterial Pneumonia
Merck Sharp & Dohme LLC 274
Testing effectiveness (Phase 2)Study completedNCT04215991
What this trial is testing

Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Pediatric Participants

Who this might be right for
Gram-negative Bacterial InfectionsHospital Acquired Bacterial Pneumonia (HABP)Complicated Urinary Tract Infection (cUTI)+1 more
Shionogi 91
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07431307
What this trial is testing

Safety, Pharmacokinetics and Efficacy of BV100 Plus Low Dose Polymyxin B Plus Ceftazidime/Avibactam, or Plus Cefiderocol in Patients With Pulmonary and Extrapulmonary Infections Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex

Who this might be right for
Ventilator Associated Bacterial Pneumonia (VABP)Hospital Acquired Bacterial Pneumonia (HABP)Blood Stream Infection+2 more
BioVersys AG
Large-scale testing (Phase 3)Study completedNCT05204563
What this trial is testing

Imipenem/Cilastatin-XNW4107 Versus Imipenem/Cilastatin/Relebactam for Treatment of Participants With Bacterial Pneumonia (XNW4107-302, REITAB-2)

Who this might be right for
Hospital Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia
Evopoint Biosciences Inc. 450
Not applicableStudy completedNCT03711331
What this trial is testing

Impact of a Strategy Based on Bacterial DNA Detection to Optimize Antibiotics in Patients With Hospital-acquired Pneumonia

Who this might be right for
Pneumonia, Ventilator-AssociatedPneumonia, Bacterial
University Hospital, Lille 161
Large-scale testing (Phase 3)Not Yet RecruitingNCT07326540
What this trial is testing

Efficacy and Safety of BV100 Plus Low Dose Polymyxin B Versus Colistin Plus High-dose Ampicillin/Sulbactam in Patients With Hospital-acquired or Ventilator-associated Bacterial Pneumonia Due to Carbapenem-resistant Acinetobacter Baumannii-calcoaceticus Complex

Who this might be right for
Hospital Acquired Bacterial Pneumonia (HABP)Ventilator Associated Bacterial Pneumonia (VABP)Colistin Resistanrt ABC+1 more
BioVersys SAS
Not applicableActive Not RecruitingNCT05405491
What this trial is testing

Impact of a Strategy Based on Bacterial DNA Detection to Optimize Antibiotics in Immunocompromised Patients With Hospital-acquired Pneumonia Requiring Mechanical Ventilation

Who this might be right for
Pneumonia, Ventilator-AssociatedPneumonia, Hospital-AcquiredImmunodeficiency
University Hospital, Lille 31
Early research (Phase 1)Looking for participantsNCT06801223
What this trial is testing

Assess Sulbactam-durlobactam in Pediatric Patients With Acinetobacter Baumannii-calcoaceticus Complex Infection

Who this might be right for
Acinetobacter Baumannii-calcoaceticus Complex Infection (ABC)
Innoviva Specialty Therapeutics 48
Large-scale testing (Phase 3)Study completedNCT03032380
What this trial is testing

Clinical Study of Cefiderocol (S-649266) for the Treatment of Nosocomial Pneumonia Caused by Gram-negative Pathogens

Who this might be right for
Healthcare-associated Pneumonia (HCAP)Hospital Acquired Pneumonia (HAP)Ventilator Associated Pneumonia (VAP)
Shionogi 300
Testing effectiveness (Phase 2)Study completedNCT06086626
What this trial is testing

Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Neonates and Infants

Who this might be right for
Gram-Negative Bacterial Infections
Shionogi 30
Testing effectiveness (Phase 2)Looking for participantsNCT06087536
What this trial is testing

A Clinical Trial to Assess the Safety and PK of OMN6 in HABP or VABP Caused by Acinetobacter Baumannii Complex

Who this might be right for
Hospital-acquired Bacterial PneumoniaVentilator-associated Bacterial Pneumonia
Omnix Medical Ltd 54
Large-scale testing (Phase 3)Study completedNCT02493764
What this trial is testing

Imipenem/Relebactam/Cilastatin Versus Piperacillin/Tazobactam for Treatment of Participants With Bacterial Pneumonia (MK-7655A-014)

Who this might be right for
Bacterial Pneumonia
Merck Sharp & Dohme LLC 537
Testing effectiveness (Phase 2)Looking for participantsNCT06841731
What this trial is testing

A Trial of HRS-8427 in the Treatment of Adults With Bacterial Pneumonia

Who this might be right for
Hospital-acquired Bacterial Pneumonia (HABP)Ventilator-associated Bacterial Pneumonia (VABP)
Jiangsu HengRui Medicine Co., Ltd. 100
Testing effectiveness (Phase 2)Study completedNCT04335539
What this trial is testing

Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of Cefiderocol in Hospitalized Pediatric Participants

Who this might be right for
Gram-negative Bacterial InfectionsBloodstream Infections (BSI)Complicated Intra-abdominal Infection (cIAI)+4 more
Shionogi 53
120
248